Time-action characteristics of regular and NPH insulin in insulin-treated diabetics
- PMID: 6987253
- DOI: 10.1210/jcem-50-3-475
Time-action characteristics of regular and NPH insulin in insulin-treated diabetics
Abstract
The time course of action of regular and NPH insulins injected sc was studied in 15 insulin-treated diabetics over a 24-h period during which they received a constant infusion of glucose. The blood glucose began to decline in 1.2 +/- 0.1 h (range, 0.5--2) and reached its nadir in 5.7 +/- 0.3 h (range, 4--8) after the sc injection of regular insulin. The peak effect of regular insulin usually persisted for several hours, and the total duration of action was 16.2 +/- 1.1 h (range, 9--24). Both the time of peak effect and the total duration of action were considerably prolonged compared to data provided in standard textbooks. Free insulin increased to a peak in 2.7 +/- 0.3 h (range, 1--4) after regular insulin injection and then returned to baseline by 8.8 +/- 0.96 h. Subcutaneous injection of NPH insulin decreased the blood glucose by 2.4 +/- 0.5 h (range, 1--7), with a maximal effect at 11.0 +/- 1.4 h (range, 5--19). The total duration of effect on blood glucose was 25.1 +/- 0.7 h (range, 20--29). These values are similar to those in standard textbooks. Although the total insulin levels increased after the injection of NPH insulin, there was very little if any elevation in free insulin. Recognition of the prolonged effect of regular insulin is important in establishing an insulin treatment regime for diabetic patients.
Similar articles
-
Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.J Clin Endocrinol Metab. 1986 Apr;62(4):621-7. doi: 10.1210/jcem-62-4-621. J Clin Endocrinol Metab. 1986. PMID: 3512590
-
[Clinical use of NPH insulin (author's transl)].Dtsch Med Wochenschr. 1976 Jun 4;101(23):886-9. doi: 10.1055/s-0028-1104135. Dtsch Med Wochenschr. 1976. PMID: 1269430 German.
-
Human (recombinant DNA) and porcine NPH insulins are unequally effective in diabetic patients. A comparative study using continuous blood glucose monitoring.Acta Diabetol Lat. 1984 Jul-Sep;21(3):211-7. doi: 10.1007/BF02642894. Acta Diabetol Lat. 1984. PMID: 6393670 Clinical Trial.
-
Insulin glargine (Lantus).Int J Clin Pract. 2002 Jul-Aug;56(6):460-6. Int J Clin Pract. 2002. PMID: 12166545 Review.
-
Can we reduce hypoglycaemia with insulin detemir?Int J Obes Relat Metab Disord. 2004 Sep;28 Suppl 2:S35-40. doi: 10.1038/sj.ijo.0802748. Int J Obes Relat Metab Disord. 2004. PMID: 15306836 Review.
Cited by
-
National athletic trainers' association position statement: management of the athlete with type 1 diabetes mellitus.J Athl Train. 2007 Oct-Dec;42(4):536-45. J Athl Train. 2007. PMID: 18176622 Free PMC article.
-
Recent developments in the management of diabetes mellitus.Indian J Pediatr. 1982 Jul-Aug;49(399):589-604. doi: 10.1007/BF02834568. Indian J Pediatr. 1982. PMID: 6759381 Review. No abstract available.
-
Smoking and insulin absorption.Br Med J (Clin Res Ed). 1984 Oct 20;289(6451):1077. doi: 10.1136/bmj.289.6451.1077-b. Br Med J (Clin Res Ed). 1984. PMID: 6435779 Free PMC article. No abstract available.
-
The new insulins. Their characteristics and clinical indications.Drugs. 1982 Nov;24(5):401-13. doi: 10.2165/00003495-198224050-00003. Drugs. 1982. PMID: 6756879 Review.
-
Absorption of isophane (NPH) insulin and its clinical implications.Br Med J (Clin Res Ed). 1982 Jul 17;285(6336):159-62. doi: 10.1136/bmj.285.6336.159. Br Med J (Clin Res Ed). 1982. PMID: 6807390 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical